Group 1 - The core viewpoint of the report indicates that Langzi Co., Ltd. experienced a decline in revenue but a significant increase in net profit for the first half of 2025, with total revenue of 2.788 billion yuan, down 4.30% year-on-year, and net profit attributable to shareholders of 274 million yuan, up 64.09% year-on-year [2] - The fashion women's clothing segment enhanced brand strength through new product launches and digital transformation initiatives, achieving a total online payment amount of 1.65 billion yuan, a year-on-year increase of 30% [2] - In the medical aesthetics sector, the company focused on safety and quality, with 8 medical institutions receiving TUV-SQS certification and 5 obtaining 5A hospital qualifications, while also establishing 7 medical aesthetics acquisition funds with a total scale of 2.837 billion yuan [3][4] Group 2 - The company optimized its supply chain management, achieving a procurement rate of 91.5% in the medical aesthetics business, with a significant increase in the procurement rates of main materials and auxiliary materials [4] - Langzi Co., Ltd. reduced costs effectively, with a procurement price reduction rate of 9.1% [4] - The company expanded its medical aesthetics business nationwide, operating 42 medical beauty institutions by the end of the first half of the year, with a focus on community-based services [4]
朗姿股份上半年实现营业收入27.88亿元 净利润同比增长64.09%